HTB homepage • Conference reports • Articles by subject • Subscribe 21 May 2018 Contents Editorial 21 May 2018: vol 19 no 9: DTG Alert and BHIVA/BASHH reports Treatment alerts Potential safety signal for dolutegravir from the time of conception Conference reports Fourth Joint Conference of BHIVA/BASHH (4th BHIVA/BASHH) Low PEP and PrEP awareness among trans people in London and their partners Low awareness of PrEP in BME communities in Leeds but high interest in use Younger people living with HIV more likely to have a positive self image Zero or negligible risks of HIV, HBV or HCV transmission by biting or spitting UK-CAB community representation on guideline panels and research studies Treatment access Phase 3 registrational data is not sufficient for roll-out of new ARVs in low- and middle-income countries Generic manufacturers from South Africa and South Korea join Medicine Patent Pool (MPP) WHO releases first list for essential diagnostics Campaign forces Government U-turn on linking NHS data to immigration service Pregnancy Dolutegravir in pregnancy: early data reassuring but ongoing surveillance is still essential Paediatric care FDA guidance for developing paediatric ARVs: online for comment (2018) Coinfections and complications US study tracks kidney transplant results from HIV positive donors Basic science and immunology New online animation of HIV lifecycle Other news St Stephen’s AIDS Trust to close after 30 years of HIV research PDFs 21 May 2018: vol 19 no 9 HTB homepage • Conference reports • Articles by subject • Subscribe
